These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 3456706)

  • 1. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
    Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
    Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.
    Gmür J; Burger J; Schanz U; Fehr J; Schaffner A
    Lancet; 1991 Nov; 338(8777):1223-6. PubMed ID: 1682642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
    Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
    Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion.
    Vavricka SR; Walter RB; Irani S; Halter J; Schanz U
    Ann Hematol; 2003 Sep; 82(9):570-3. PubMed ID: 12904898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for platelet transfusion in children with acute leukemia.
    Murphy S; Litwin S; Herring LM; Koch P; Remischovsky J; Donaldson MH; Evans AE; Gardner FH
    Am J Hematol; 1982 Jun; 12(4):347-56. PubMed ID: 6981349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia.
    Howard SC; Gajjar A; Ribeiro RC; Rivera GK; Rubnitz JE; Sandlund JT; Harrison PL; de Armendi A; Dahl GV; Pui CH
    JAMA; 2000 Nov; 284(17):2222-4. PubMed ID: 11056594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
    Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
    N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
    Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ex-vivo bleeding time as a control for platelet transfusion].
    Söhngen D; Hattstein E; Heyll A; Kuntz BM; Meckenstock G; Schneider W
    Beitr Infusionsther Transfusionsmed; 1994; 32():459-66. PubMed ID: 9480143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowering the prophylactic platelet transfusion threshold: a prospective analysis.
    Lawrence JB; Yomtovian RA; Hammons T; Masarik SR; Chongkolwatana V; Creger RJ; Manka A; Lazarus HM
    Leuk Lymphoma; 2001 Mar; 41(1-2):67-76. PubMed ID: 11342358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
    Estcourt LJ; Stanworth SJ; Murphy MF
    JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
    Vinholt PJ; Alnor A; Nybo M; Hvas AM
    Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
    Lye DC; Lee VJ; Sun Y; Leo YS
    Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates.
    Hoque MM; Rahman M; Rahman SM; Habibullah MM; Faruki MA; Rahman KH; Mamun AA; Hossain MA
    Mymensingh Med J; 2013 Jan; 22(1):64-8. PubMed ID: 23416811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.